FDA Approved: ICATIBANT — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for icatibant by Eugia US LLC under an Abbreviated New Drug Application (ANDA), marking regulatory approval of the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

SUPPL AP for ICATIBANT (ICATIBANT)